Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
52
DSFIY Quote, Financials, Valuation and Earnings
Last price:
$8.13
Seasonality move
:
-2.4%
Day range:
$8.03 - $8.41
52-week range:
$7.75 - $11.57
Dividend yield:
1.48%
P/E ratio:
27.41x
P/S ratio:
1.52x
P/B ratio:
1.00x
Volume:
359K
Avg. volume:
320.9K
1-year change:
-19.98%
Market cap:
$21.1B
Revenue:
$13.8B
EPS (TTM):
$0.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DSFIY
DSM-Firmenich AG
|
-- | -- | -- | -- | -- |
|
AMRZ
Amrize AG
|
-- | -- | -- | -- | -- |
|
BCHMY
Bachem Holding AG
|
-- | -- | -- | -- | -- |
|
CLZNY
Clariant AG
|
$1.2B | -- | -- | -- | -- |
|
GVDNY
Givaudan SA
|
-- | -- | -- | -- | -- |
|
HCMLY
Holcim Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DSFIY
DSM-Firmenich AG
|
$8.13 | -- | $21.1B | 27.41x | $0.28 | 1.48% | 1.52x |
|
AMRZ
Amrize AG
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
BCHMY
Bachem Holding AG
|
$7.24 | -- | $5.4B | 35.13x | $0.05 | 0.71% | 6.95x |
|
CLZNY
Clariant AG
|
$8.83 | -- | $2.9B | 22.44x | $0.44 | 0% | 0.62x |
|
GVDNY
Givaudan SA
|
$79.39 | -- | $36.6B | 29.16x | $1.58 | 1.99% | 4.23x |
|
HCMLY
Holcim Ltd.
|
$19.69 | -- | $54.2B | 3.05x | $10.63 | 0% | 2.21x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DSFIY
DSM-Firmenich AG
|
20.27% | 0.210 | -- | 1.73x |
|
AMRZ
Amrize AG
|
-- | 0.000 | -- | -- |
|
BCHMY
Bachem Holding AG
|
-- | 0.574 | -- | 0.78x |
|
CLZNY
Clariant AG
|
42.02% | -0.351 | -- | 1.01x |
|
GVDNY
Givaudan SA
|
51.65% | -0.179 | -- | 0.75x |
|
HCMLY
Holcim Ltd.
|
-- | 0.652 | -- | 1.07x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DSFIY
DSM-Firmenich AG
|
-- | -- | 2.7% | 3.3% | -- | -- |
|
AMRZ
Amrize AG
|
-- | -- | -- | -- | -- | -- |
|
BCHMY
Bachem Holding AG
|
-- | -- | 9.99% | 9.99% | -- | -- |
|
CLZNY
Clariant AG
|
-- | -- | 6.19% | 10.24% | -- | -- |
|
GVDNY
Givaudan SA
|
-- | -- | 12.56% | 25.75% | -- | -- |
|
HCMLY
Holcim Ltd.
|
-- | -- | 58.83% | 69.32% | -- | -- |
DSM-Firmenich AG vs. Competitors
-
Which has Higher Returns DSFIY or AMRZ?
Amrize AG has a net margin of -- compared to DSM-Firmenich AG's net margin of --. DSM-Firmenich AG's return on equity of 3.3% beat Amrize AG's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DSFIYDSM-Firmenich AG-- -- $31.6B AMRZAmrize AG-- -- -- -
What do Analysts Say About DSFIY or AMRZ?
DSM-Firmenich AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Amrize AG has an analysts' consensus of -- which suggests that it could fall by --. Given that DSM-Firmenich AG has higher upside potential than Amrize AG, analysts believe DSM-Firmenich AG is more attractive than Amrize AG.
Company Buy Ratings Hold Ratings Sell Ratings DSFIYDSM-Firmenich AG0 0 0 AMRZAmrize AG0 0 0 -
Is DSFIY or AMRZ More Risky?
DSM-Firmenich AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amrize AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DSFIY or AMRZ?
DSM-Firmenich AG has a quarterly dividend of $0.28 per share corresponding to a yield of 1.48%. Amrize AG offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DSM-Firmenich AG pays 219.34% of its earnings as a dividend. Amrize AG pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DSFIY or AMRZ?
DSM-Firmenich AG quarterly revenues are --, which are smaller than Amrize AG quarterly revenues of --. DSM-Firmenich AG's net income of -- is lower than Amrize AG's net income of --. Notably, DSM-Firmenich AG's price-to-earnings ratio is 27.41x while Amrize AG's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DSM-Firmenich AG is 1.52x versus -- for Amrize AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DSFIYDSM-Firmenich AG1.52x 27.41x -- -- AMRZAmrize AG-- -- -- --
-
Which has Higher Returns DSFIY or BCHMY?
Bachem Holding AG has a net margin of -- compared to DSM-Firmenich AG's net margin of --. DSM-Firmenich AG's return on equity of 3.3% beat Bachem Holding AG's return on equity of 9.99%.
Company Gross Margin Earnings Per Share Invested Capital DSFIYDSM-Firmenich AG-- -- $31.6B BCHMYBachem Holding AG-- -- $1.7B -
What do Analysts Say About DSFIY or BCHMY?
DSM-Firmenich AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Bachem Holding AG has an analysts' consensus of -- which suggests that it could fall by --. Given that DSM-Firmenich AG has higher upside potential than Bachem Holding AG, analysts believe DSM-Firmenich AG is more attractive than Bachem Holding AG.
Company Buy Ratings Hold Ratings Sell Ratings DSFIYDSM-Firmenich AG0 0 0 BCHMYBachem Holding AG0 0 0 -
Is DSFIY or BCHMY More Risky?
DSM-Firmenich AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Bachem Holding AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DSFIY or BCHMY?
DSM-Firmenich AG has a quarterly dividend of $0.28 per share corresponding to a yield of 1.48%. Bachem Holding AG offers a yield of 0.71% to investors and pays a quarterly dividend of $0.05 per share. DSM-Firmenich AG pays 219.34% of its earnings as a dividend. Bachem Holding AG pays out 35.37% of its earnings as a dividend. Bachem Holding AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but DSM-Firmenich AG's is not.
-
Which has Better Financial Ratios DSFIY or BCHMY?
DSM-Firmenich AG quarterly revenues are --, which are smaller than Bachem Holding AG quarterly revenues of --. DSM-Firmenich AG's net income of -- is lower than Bachem Holding AG's net income of --. Notably, DSM-Firmenich AG's price-to-earnings ratio is 27.41x while Bachem Holding AG's PE ratio is 35.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DSM-Firmenich AG is 1.52x versus 6.95x for Bachem Holding AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DSFIYDSM-Firmenich AG1.52x 27.41x -- -- BCHMYBachem Holding AG6.95x 35.13x -- --
-
Which has Higher Returns DSFIY or CLZNY?
Clariant AG has a net margin of -- compared to DSM-Firmenich AG's net margin of --. DSM-Firmenich AG's return on equity of 3.3% beat Clariant AG's return on equity of 10.24%.
Company Gross Margin Earnings Per Share Invested Capital DSFIYDSM-Firmenich AG-- -- $31.6B CLZNYClariant AG-- -- $4.6B -
What do Analysts Say About DSFIY or CLZNY?
DSM-Firmenich AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Clariant AG has an analysts' consensus of -- which suggests that it could fall by --. Given that DSM-Firmenich AG has higher upside potential than Clariant AG, analysts believe DSM-Firmenich AG is more attractive than Clariant AG.
Company Buy Ratings Hold Ratings Sell Ratings DSFIYDSM-Firmenich AG0 0 0 CLZNYClariant AG0 0 0 -
Is DSFIY or CLZNY More Risky?
DSM-Firmenich AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Clariant AG has a beta of 0.449, suggesting its less volatile than the S&P 500 by 55.062%.
-
Which is a Better Dividend Stock DSFIY or CLZNY?
DSM-Firmenich AG has a quarterly dividend of $0.28 per share corresponding to a yield of 1.48%. Clariant AG offers a yield of 0% to investors and pays a quarterly dividend of $0.44 per share. DSM-Firmenich AG pays 219.34% of its earnings as a dividend. Clariant AG pays out 52.53% of its earnings as a dividend. Clariant AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but DSM-Firmenich AG's is not.
-
Which has Better Financial Ratios DSFIY or CLZNY?
DSM-Firmenich AG quarterly revenues are --, which are smaller than Clariant AG quarterly revenues of --. DSM-Firmenich AG's net income of -- is lower than Clariant AG's net income of --. Notably, DSM-Firmenich AG's price-to-earnings ratio is 27.41x while Clariant AG's PE ratio is 22.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DSM-Firmenich AG is 1.52x versus 0.62x for Clariant AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DSFIYDSM-Firmenich AG1.52x 27.41x -- -- CLZNYClariant AG0.62x 22.44x -- --
-
Which has Higher Returns DSFIY or GVDNY?
Givaudan SA has a net margin of -- compared to DSM-Firmenich AG's net margin of --. DSM-Firmenich AG's return on equity of 3.3% beat Givaudan SA's return on equity of 25.75%.
Company Gross Margin Earnings Per Share Invested Capital DSFIYDSM-Firmenich AG-- -- $31.6B GVDNYGivaudan SA-- -- $10.6B -
What do Analysts Say About DSFIY or GVDNY?
DSM-Firmenich AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Givaudan SA has an analysts' consensus of -- which suggests that it could fall by --. Given that DSM-Firmenich AG has higher upside potential than Givaudan SA, analysts believe DSM-Firmenich AG is more attractive than Givaudan SA.
Company Buy Ratings Hold Ratings Sell Ratings DSFIYDSM-Firmenich AG0 0 0 GVDNYGivaudan SA0 0 0 -
Is DSFIY or GVDNY More Risky?
DSM-Firmenich AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Givaudan SA has a beta of 0.787, suggesting its less volatile than the S&P 500 by 21.261%.
-
Which is a Better Dividend Stock DSFIY or GVDNY?
DSM-Firmenich AG has a quarterly dividend of $0.28 per share corresponding to a yield of 1.48%. Givaudan SA offers a yield of 1.99% to investors and pays a quarterly dividend of $1.58 per share. DSM-Firmenich AG pays 219.34% of its earnings as a dividend. Givaudan SA pays out 35.74% of its earnings as a dividend. Givaudan SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but DSM-Firmenich AG's is not.
-
Which has Better Financial Ratios DSFIY or GVDNY?
DSM-Firmenich AG quarterly revenues are --, which are smaller than Givaudan SA quarterly revenues of --. DSM-Firmenich AG's net income of -- is lower than Givaudan SA's net income of --. Notably, DSM-Firmenich AG's price-to-earnings ratio is 27.41x while Givaudan SA's PE ratio is 29.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DSM-Firmenich AG is 1.52x versus 4.23x for Givaudan SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DSFIYDSM-Firmenich AG1.52x 27.41x -- -- GVDNYGivaudan SA4.23x 29.16x -- --
-
Which has Higher Returns DSFIY or HCMLY?
Holcim Ltd. has a net margin of -- compared to DSM-Firmenich AG's net margin of --. DSM-Firmenich AG's return on equity of 3.3% beat Holcim Ltd.'s return on equity of 69.32%.
Company Gross Margin Earnings Per Share Invested Capital DSFIYDSM-Firmenich AG-- -- $31.6B HCMLYHolcim Ltd.-- -- $19.2B -
What do Analysts Say About DSFIY or HCMLY?
DSM-Firmenich AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Holcim Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that DSM-Firmenich AG has higher upside potential than Holcim Ltd., analysts believe DSM-Firmenich AG is more attractive than Holcim Ltd..
Company Buy Ratings Hold Ratings Sell Ratings DSFIYDSM-Firmenich AG0 0 0 HCMLYHolcim Ltd.0 0 0 -
Is DSFIY or HCMLY More Risky?
DSM-Firmenich AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Holcim Ltd. has a beta of 1.029, suggesting its more volatile than the S&P 500 by 2.9%.
-
Which is a Better Dividend Stock DSFIY or HCMLY?
DSM-Firmenich AG has a quarterly dividend of $0.28 per share corresponding to a yield of 1.48%. Holcim Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $10.63 per share. DSM-Firmenich AG pays 219.34% of its earnings as a dividend. Holcim Ltd. pays out 58.67% of its earnings as a dividend. Holcim Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but DSM-Firmenich AG's is not.
-
Which has Better Financial Ratios DSFIY or HCMLY?
DSM-Firmenich AG quarterly revenues are --, which are smaller than Holcim Ltd. quarterly revenues of --. DSM-Firmenich AG's net income of -- is lower than Holcim Ltd.'s net income of --. Notably, DSM-Firmenich AG's price-to-earnings ratio is 27.41x while Holcim Ltd.'s PE ratio is 3.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DSM-Firmenich AG is 1.52x versus 2.21x for Holcim Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DSFIYDSM-Firmenich AG1.52x 27.41x -- -- HCMLYHolcim Ltd.2.21x 3.05x -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
